Tanvex BioPharma Market Cap

Tanvex BioPharma has a market cap or net worth of 10.56 billion as of October 14, 2024. Its market cap has increased by 32.38% in one year.

Market Cap

10.56B

Enterprise Value

11.26B

Revenue

34.56M

Ranking

n/a

PE Ratio

n/a

Stock Price

63.70

Market Cap Chart

Since August 13, 2015, Tanvex BioPharma's market cap has decreased from 16.77B to 10.56B, a decrease of -37.01%. That is a compound annual growth rate of -4.91%.

Market Cap History

Date	Market Cap	% Change
Oct 14, 2024	10.56B	21.21%
Dec 29, 2023	8.71B	-29.59%
Dec 30, 2022	12.38B	-39.56%
Dec 30, 2021	20.48B	106.96%
Dec 31, 2020	9.89B	-9.41%
Dec 31, 2019	10.92B	-27.99%
Dec 28, 2018	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition